The recommendations come as four Indian drug companies, Cipla, Hetero, Mylan and Jubilant, gear up to get an approval for the drug in the treatment of Covid-19.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3eCZqmx
via IFTTT
The recommendations come as four Indian drug companies, Cipla, Hetero, Mylan and Jubilant, gear up to get an approval for the drug in the treatment of Covid-19.
No comments:
Post a Comment